Imunon (IMNN) Revenue & Revenue Breakdown
Imunon Revenue Highlights
Imunon Revenue by Period
Imunon Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $500.00K | - |
| 2021-12-31 | $500.00K | - |
| 2020-12-31 | $500.00K | - |
| 2019-12-31 | $500.00K | - |
| 2018-12-31 | $500.00K | - |
| 2017-12-31 | $500.00K | - |
| 2016-12-31 | $500.00K | - |
| 2015-12-31 | $500.00K | - |
| 2014-12-31 | $500.00K | - |
| 2013-12-31 | $500.00K | 100.00% |
| 2012-12-31 | - | -100.00% |
| 2011-12-31 | $2.00M | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | -100.00% |
| 2008-12-31 | $2.50M | 100.00% |
| 2007-12-31 | - | -100.00% |
| 2006-12-31 | $11.25M | -8.68% |
| 2005-12-31 | $12.32M | 391.58% |
| 2004-12-31 | $2.51M | 100.00% |
| 2003-09-30 | - | 100.00% |
| 2002-09-30 | - | 100.00% |
| 2001-09-30 | - | -100.00% |
| 2000-09-30 | $3.42K | -96.58% |
| 1999-09-30 | $100.00K | -42.59% |
| 1998-09-30 | $174.18K | 43.65% |
| 1997-09-30 | $121.26K | 63.85% |
| 1996-09-30 | $74.01K | - |
Imunon generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Imunon Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $7.05M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $125.00K | - |
| 2022-09-30 | $125.00K | - |
| 2022-06-30 | $125.00K | - |
| 2022-03-31 | $125.00K | - |
| 2021-12-31 | $125.00K | - |
| 2021-09-30 | $125.00K | - |
| 2021-06-30 | $125.00K | - |
| 2021-03-31 | $125.00K | - |
| 2020-12-31 | $125.00K | - |
| 2020-09-30 | $125.00K | - |
| 2020-06-30 | $125.00K | - |
| 2020-03-31 | $125.00K | - |
| 2019-12-31 | $125.00K | - |
| 2019-09-30 | $125.00K | - |
| 2019-06-30 | $125.00K | - |
| 2019-03-31 | $125.00K | - |
| 2018-12-31 | $125.00K | - |
| 2018-09-30 | $125.00K | - |
| 2018-06-30 | $125.00K | - |
| 2018-03-31 | $125.00K | - |
| 2017-12-31 | $125.00K | - |
| 2017-09-30 | $125.00K | - |
| 2017-06-30 | $125.00K | - |
| 2017-03-31 | $125.00K | - |
| 2016-12-31 | $125.00K | - |
| 2016-09-30 | $125.00K | - |
| 2016-06-30 | $125.00K | - |
| 2016-03-31 | $125.00K | - |
| 2015-12-31 | $125.00K | - |
| 2015-09-30 | $125.00K | - |
| 2015-06-30 | $125.00K | - |
| 2015-03-31 | $125.00K | - |
| 2014-12-31 | $125.00K | - |
| 2014-09-30 | $125.00K | - |
| 2014-06-30 | $125.00K | - |
| 2014-03-31 | $125.00K | - |
| 2013-12-31 | $125.00K | - |
| 2013-09-30 | $125.00K | - |
| 2013-06-30 | $125.00K | - |
| 2013-03-31 | $125.00K | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | -100.00% |
| 2011-03-31 | $2.00M | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | - |
Imunon generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Imunon Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KA | Kineta | $5.44M | - |
| HSTO | Histogen | $3.77M | $5.00K |
| SNTI | Senti Biosciences | $2.56M | - |
| SABS | SAB Biotherapeutics | $2.24M | $263.14K |
| LUMO | Lumos Pharma | $2.05M | $488.00K |
| BLCM | Bellicum Pharmaceuticals | $1.50M | $1.00M |
| AVTX | Avalo Therapeutics | $1.41M | - |
| CBIO | Gyre Therapeutics | $794.00K | - |
| CYCC | Cyclacel Pharmaceuticals | $420.00K | $4.00 |
| IMNN | Imunon | - | - |
| XCUR | Exicure | - | - |
| TOVX | Theriva Biologics | - | - |
| LSTA | Lisata Therapeutics | - | - |
| LIXT | Lixte Biotechnology | - | - |
| DMAC | DiaMedica Therapeutics | - | - |
| CING | Cingulate | - | - |
| HILS | Tharimmune | - | - |
| NLTX | Neurogene | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| DFFN | CervoMed | - | - |
IMNN Revenue FAQ
What is Imunon’s yearly revenue?
Imunon's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $500K, representing an increase of 0% compared to 2021. IMNN's yearly revenue for 2021 was $500K, representing an increase of 0% compared to 2020.
What is Imunon’s quarterly revenue?
Imunon's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $7.05M, a 100.00% increase from the previous quarter (Q3 2023), and a 5540.59% increase year-over-year (Q4 2022). IMNN's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).
What is Imunon’s revenue growth rate?
Imunon's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.